Ying-Hsia Chu

Biography

Ying-Hsia received her M.D. from the National Taiwan University School of Medicine in 2014, having done a year of research in Singapore focused on outcome predictors for TKI therapy in renal cancer and working with refugees at the Thai-Burma border. She enjoys reading, cooking, trying new restaurants, and travel. She will be graduating in 2019 to start a Head and Neck Pathology Fellowship at Massachusetts General Hospital in Boston followed by a Molecular Genetic Pathology Fellowship at Memorial Sloan Kettering Cancer Center in New York.

Education

National Taiwan University Ying-Hsia Chu

Publications

Guo Z, Ge M, Chu YH, Asioli S, Lloyd RV. “Recent advances in the classification of low grade papillary-like thyroid neoplasms and aggressive papillary thyroid carcinomas: Evolution of diagnostic criteria.” Advances in Anatomic Pathology 2018 Jul;25(4):263-272.

Chu YH, Huang W, Hu R. “Exclusively Intertubular Seminoma Arising in Undescended Testes: Report of Two Cases.” Human Pathology: Case Reports 2018; 11:15-18.

Chu Y-H, Hardin H, Schneider DF, Chen H, Lloyd RV. “MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.” Exp. Mol. Pathol. 2017;103(2):229-236.

Chu YH, Sterkel AK, Brooks EG. “Autopsy Diagnosis of Capnocytophaga canimorsus Sepsis.” ASCP Case Reports: Forensic Pathology 2017; FP17-6: 1-19.

Chu Y-H, Lloyd RV. “Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.” Endocr. Pathol. 2016;27(4):312-324.